Michael Kyriakides
Principal
Michael Kyriakides is a Principal of Syncona Investment Management Limited.
He works closely with Syncona portfolio companies Spur Therapeutics, Purespring Therapeutics and Beacon Therapeutics. He previously also supported Nightstar Therapeutics, Gyroscope Therapeutics and Clade Therapeutics. Prior to joining Syncona, Michael was a member of the Life Sciences team at L.E.K. Consulting and a clinical project and NMR manager in the Faculty of Medicine at Imperial College London. Michael obtained his doctorate degree in toxicology and metabolic profiling at Imperial College London.
Syncona portfolio companies
- Purespring Therapeutics (Board member)
- Beacon Therapeutics (Board observer)
- Purespring Therapeutics (Board member)
